Everest Financial Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$237K Hold
871
– – 0.03% 207
2026
Q2
$216K Buy
+871
New +$188K 0.03% 198

Other funds holding FBT

Everest Financial Group's FBT Position: Q3 2026 in Review

Everest Financial Group held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 871 shares worth $237K. The position accounts for 0.03% of the portfolio, ranked #207.

Everest Financial Group first reported a position in FBT in Q2 2026 and has held it in 2 quarters since. 350 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Everest Financial Group held 871 shares of First Trust NYSE Arca Biotechnology Index Fund worth $237K as of Q3 2026.
  • Everest Financial Group left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Everest Financial Group's portfolio in Q3 2026, its #207 holding.
  • Everest Financial Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2026 and has held it in 2 quarters since.
  • 350 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Everest Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.